Skip to main content
ARTL
NASDAQ Life Sciences

Artelo Biosciences Executes Reverse Split to Boost Share Price and Liquidity

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.69
Mkt Cap
$3.265M
52W Low
$0.66
52W High
$28.14
52W Position info
4.5% above low
Off High info
98% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ARTL is trading near its 52-week low of $0.66 (4.5% above the low) on light trading volume (0.3× avg).

Summary

Artelo Biosciences is effecting a 1-for-9 reverse stock split effective Aug. 28, 2026, to raise its per-share price and improve marketability and liquidity. The split reduces outstanding shares from 4,929,966 to about 547,774 and authorized shares from 500 million to 55,555,556, with trading on a split-adjusted basis beginning Aug. 31. The company trades near its 52-week low at $0.69, and the split follows shareholder approval in July of a 3x increase in authorized shares and a highly dilutive financing agreement with Square Gate Capital. The reverse split is a mechanical step to maintain Nasdaq listing compliance and attract institutional interest, but it does not change the company's underlying fundamentals or cash position. With only $4.2 million in cash and going concern doubts reiterated in the latest 10-Q, the split may be a precursor to further capital raises.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — The 1-for-9 reverse split is effective Aug. 28, 2026, reducing outstanding shares from 4,929,966 to about 547,774 and authorized shares from 500 million to 55,555,556. Trading on a split-adjusted basis begins Aug. 31.

At the time of this announcement, ARTL was trading at $0.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.66 to $28.14. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ARTL - Latest Insights

ARTL
Nov 12, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.24
Real-time Price: $1.69 info
Change: -$0.5508 (-25%) info
Market Cap: $1.593M info
ARTL
Oct 09, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.19
Real-time Price: $1.69 info
Change: -$1.50 (-47%) info
Market Cap: $1.593M info
ARTL
Sep 23, 2026, 1:46 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $7.84
Real-time Price: $1.69 info
Change: -$6.15 (-78%) info
Market Cap: $1.593M info
ARTL
Sep 16, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.02
Real-time Price: $1.69 info
Change: -$3.33 (-66%) info
Market Cap: $1.593M info
ARTL
Aug 27, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.658
Real-time Price: $1.69 info
Change: Reverse Stock Split info
Market Cap: $1.593M info